Biotechnology & Enzyme

2021 Conferences & Webinars

Cancelled
CELL CULTURE ENGINEERING XVII
(Tucson, Arizona) — 20AC
We regret that the CCE XVII had to be cancelled as the Covid-19 pandemic made it impossible to meet in person.  We thank everyone who was planning to participate for their understanding and especially thank the conference chairs (Tim CharleboisJamey Young and Gargi Maheshwari) for their gargantuan effort, patience and dedication.  We also wish to similarly thank the poster session chairs (Karthik JayapalShawn LawrenceOlivier Henry and Yao-Ming Huang), the workshop chairs (Laura Palomares and Anurag Khetan), the Early Careers PreConference chairs (Ioscani Jimenez del Val and Amanda Lewis), the session chairs as well as all the speakers and poster presenters.   We recognize the disappointment of the CCE community that this superb program could not brought to fruition, but now we look forward to CCE XVIII in April 2023 in Cancun, Mexico under the capable leadership of Laura PalomeresTongTong Wang, and Chetan Goudar.

2022 Conferences

Feb 6-10, 2022
ADVANCING MANUFACTURE OF CELL AND GENE THERAPIES VII — 21AT
S. Palecek, University of Wisconsin, USA; D. Marshall, Achilles Therapeutics, UK; F. Masri, Cell & Gene Therapy Catapult, UK
Coronado, CA

March 20-23, 2022
SINGLE-USE TECHNOLOGIES V: BUILDING THE FUTURE — 20AS

M. Barbaroux, Sartorius-Stedim; M. Micheletti, University College London
Marseille, France

Postponed to Spring 2024
DELIVERY OF NUCLEIC ACID THERAPEUTICS II: BIOLOGY, ENGINEERING AND DEVELOPMENT — 20AP
L. Sepp-Lorenzino; S. F. Dowdy, University of California San Diego School of Medicine, M. Stanton, Generation Bio
Siracusa, Sicily

April 3-7, 2022
MICROBIAL ENGINEERING II — 20AK
E. Keshavarz-Moore, University College London; B. Buckland, BiologicB
Albufiera, Portugal

May 15-20, 2022
NANOTECHNOLOGY IN MEDICINE III: ENABLING NEXT GENERATION THERAPIES — 20AH
M. Radisic, University of Toronto; V. Shahin, University of Munster
Cetraro (Calabria), Italy

May 22-27, 2022
ENZYME ENGINEERING XXVI – 21AE
A.Bommarius, Georgia Institute of Technology; V. Michell, Codexis; D. Furst, GSK
Dallas, Texas

June 12-17, 2022
VACCINE TECHNOLOGY VIII — 20AA
T. Mukhopadhyay, Merck Research Laboratories; C. Lutsch, Sanofi Pasteur; L. Lua, University of Queensland; F. Godia, Universitat Autònoma de Barcelona
Sitges, Spain

June 26-30, 2022
BIOCHEMICAL AND MOLECULAR ENGINEERING XXII — 21AM
K. Prather, Massachusetts Institute of Technology; M. Jewett, Northwestern University; M. Koepke, LanzaTech
Cancun, Mexico

July 10-13, 2022
ADVANCES IN COSMETIC FORMULATION DESIGN II — 20AY
S. Amin, Manhattan College; P. Somaundaran, Columbia University
Durham, NC

July 25-29, 2022
ASSOCIATION IN SOLUTION V — 21AH

I. Voets, Eindhoven University of Technology; J. Strakel, Wageningen University; J. Conrad, University of Houston
Azores, Portugal

Summer, 2022 (TBA)
SYNTACTIC AND COMPOSITE FOAMS VI — 20AF

G.M. Gladysz and K.K. Chawla, University of Alabama at Birmingham; A. R. Boccaccini, University of Erlangen-Nuremberg; M. Fukushima, National Institute of Advanced Industrial Science and Technology
Tallinn, Estonia

October 9-13, 2022
INTEGRATED CONTINUOUS BIOMANUFACTURING V — 22AA
J.  Walther, Sanofi; A. Azevedo, Instituto Superior Técnico; R. Deshpande, Amgen
Sitges, Spain

2023 Conferences

April 23-29, 2023
CELL CULTURE ENGINEERING XVIII – 22AC (Cancun, Mexico)
L. Palomares, IBT-UNAM; C. Goudar, Amgen; T. Wang, Roche

June TBD, 2023
ADVANCES IN OPTICS FOR BIOTECHNOLOGY, MEDICINE AND SURGERY — 21AO
M. Niedre, Northeastern University; F. Leblond, Polytecnique Montreal
Tomar, Portugal

Post a Comment

You must be logged in to post a comment.